INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

66,706 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M$319K
10.4K sh
Sep 18, 2026Sep 18, 2026
Page 307 of 1668
← PrevNext →
traded Sep 18, 2026
+0d
SEC Form 4

Evidence

20
SB
Sandler Alan B.Chief Development Officer
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$975
5 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

20
HK
Henderson KayaDirector
SCHLSCHOLASTIC CORP
Grant or award
A$130K
3,700 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

19
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$4,961
52 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

19
BM
Baer MattDirector, Chief Executive Officer
SFIXStitch Fix, Inc.
Tax withholding
F$338K
115.1K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

19
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$355K
12.3K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

19
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$1.53M
17.2K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

18
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$3.01M
107.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

17
AT
Allen William TDirector
SVVSavers Value Village, Inc.
Option exercise
M$17K
12.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

17
RJ
Rozenblat JennaPresident
REAXReal REMAX Group Inc.
Disposition to issuer
D—
333 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

17
FJ
Fitzpatrick JenniferCLO and Head of Program Mgmt.
SIONSionna Therapeutics, Inc.
Grant or award
A—
28.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

17
AT
Allen William TDirector
SVVSavers Value Village, Inc.
Option exercise
M$17K
12.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

17
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
18.8K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

17
FR
Furner John R.Director, President & CEO
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$646K
6,045 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

17
RJ
Rozenblat JennaPresident
REAXReal REMAX Group Inc.
Option exercise
M—
417 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

17
FR
Furner John R.Director, President & CEO
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$754K
7,080 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

16
LL
Lin LaurenCLO, CCO and Secretary
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$46K
4,574 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

16
MA
Mancini AnthonySee Remarks
RVMDRevolution Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$5,266
27 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

16
FD
Frisby Jeffry DDirector
ATROASTRONICS CORP
Option exercise
M$95K
4,000 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

16
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
2,951 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

16
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$4.31M
110.6K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

15
SI
Steward IanChief Revenue Officer
GTLBGitlab Inc.
Tax withholding
F$615K
12.6K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

15
BD
Blackman DonnaCHIEF FINANCIAL OFFICER
LRNStride, Inc.
Tax withholding
F$718K
8,747 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$19K
200 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

14
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
25.4K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$853
29 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

14
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$19K
606 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

14
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
7,197 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

14
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
10.4K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

13
KE
Kleiser Kirk E.Director
CLSTCatalyst Bancorp, Inc.
Option exercise
M—
529 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

13
LA
Lumpkin AlexandraChief Legal Officer
REAXReal REMAX Group Inc.
Disposition to issuer
D—
98 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

13
BM
Baer MattDirector, Chief Executive Officer
SFIXStitch Fix, Inc.
Option exercise
M—
61.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

13
GF
Greig Henry FDirector
SLMSLM Corp
Grant or award
A—
988 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

13
CM
Cloonan MichaelDirector, President & CEO
SIONSionna Therapeutics, Inc.
Grant or award
A—
109.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

13
CM
Cloonan MichaelDirector, President & CEO
SIONSionna Therapeutics, Inc.
Grant or award
A—
109.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

13
FD
Frisby Jeffry DDirector
ATROASTRONICS CORP
Option exercise
M$36K
1,520 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

13
AD
Aufderhaar DavidChief Financial Officer
SFIXStitch Fix, Inc.
Option exercise
M—
43.9K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

13
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$8,760
1,921 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

13
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise
M—
25.3K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

13
AT
Allen William TDirector
SVVSavers Value Village, Inc.
Option exercise
M$23K
7,135 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence